Literature DB >> 28056490

Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice.

Luca Maroni1,2, Simon D Hohenester1,3, Stan F J van de Graaf1, Dagmar Tolenaars1, Krijn van Lienden4, Joanne Verheij5, Marco Marzioni2, Tom H Karlsen6, Ronald P J Oude Elferink1, Ulrich Beuers1.   

Abstract

The etiopathogenesis of primary sclerosing cholangitis is unknown. Genetic variants of fucosyltransferase 2 (FUT2) have been identified in genome-wide association studies as risk factors for primary sclerosing cholangitis. We investigated the role of Fut2 in murine liver pathophysiology by studying Fut2-/- mice. Fut2-/- mice were viable and fertile, had lower body weight than wild-type (wt) littermates and gray fur. Half of the Fut2-/- mice showed serum bile salt levels 40 times higher than wt (Fut2-/-high ), whereas the remainder were normocholanemic (Fut2-/-low ). Fut2-/- mice showed normal serum liver tests, bile flow, biliary bile salt secretion, fecal bile salt loss, and expression of major hepatocellular bile salt transporters and cytochrome P450 7a1, the key regulator of bile salt synthesis, indicating that elevated serum bile salts in Fut2-/-high mice were not explained by cholestasis. Fut2-/-high mice, but not Fut2-/-low mice, were sensitive to hydrophobic bile salt feeding (0.3% glycochenodeoxycholate); they rapidly lost weight and showed elevation of serum liver tests (alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase) and areas of liver parenchymal necrosis. Histomorphological evaluation revealed the presence of paraportal shunting vessels, increased numbers of portal vascular structures, wall thickening of some portal arteries, and periductal fibrosis in Fut2-/-high mice more than Fut2-/-low mice and not wt mice. Unconjugated bilirubin and ammonia were or tended to be elevated in Fut2-/-high mice only. Portosystemic shunting was demonstrated by portal angiography, which disclosed virtually complete portosystemic shunting in Fut2-/-high mice, discrete portosystemic shunting in Fut2-/-low mice, and no shunting in wt littermates.
CONCLUSION: Liver pathology in Fut2-/- mice is dominated by consequences of portosystemic shunting resulting in microcirculatory disturbances, mild (secondary) periductal fibrosis, and sensitivity toward human bile salt toxicity. (Hepatology 2017;66:542-554).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28056490     DOI: 10.1002/hep.29029

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

Review 1.  Biological functions of fucose in mammals.

Authors:  Michael Schneider; Esam Al-Shareffi; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

2.  Up-regulation of FUT8 inhibits TGF-β1-induced activation of hepatic stellate cells during liver fibrogenesis.

Authors:  Mengzhen Kuang; Hao Wu; Lan Hu; Xinying Guo; Daochuan He; Bo Liu; Mengqian Chen; Jie Gu; Jianxin Gu; Xiaoqing Zeng; Yuanyuan Ruan
Journal:  Glycoconj J       Date:  2021-02-20       Impact factor: 2.916

3.  Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?

Authors:  Steven P O'Hara; Tom H Karlsen; Nicholas F LaRusso
Journal:  Gut       Date:  2017-07-21       Impact factor: 23.059

4.  Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency.

Authors:  Xuelian Tang; Weijun Wang; Gaichao Hong; Caihan Duan; Siran Zhu; Yuen Tian; Chaoqun Han; Wei Qian; Rong Lin; Xiaohua Hou
Journal:  J Biomed Sci       Date:  2021-03-15       Impact factor: 8.410

5.  Validation of a genotype-based algorithm that identifies individuals with low, intermediate, and high serum CA19-9 levels in cancer-free individuals and in patients with colorectal cancer.

Authors:  Andreas Wannhoff; Simone Werner; Sha Tao; Hermann Brenner; Daniel N Gotthardt
Journal:  J Gastrointest Oncol       Date:  2022-08

Review 6.  Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis.

Authors:  Aleksandar Arsenijevic; C Randall Harrell; Crissy Fellabaum; Vladislav Volarevic
Journal:  Anal Cell Pathol (Amst)       Date:  2017-12-19       Impact factor: 2.916

Review 7.  Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.

Authors:  Debora Maria Giordano; Claudio Pinto; Luca Maroni; Antonio Benedetti; Marco Marzioni
Journal:  Int J Mol Sci       Date:  2018-10-01       Impact factor: 5.923

8.  Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis.

Authors:  Simon Hohenester; Veronika Kanitz; Andreas E Kremer; Coen C Paulusma; Ralf Wimmer; Helen Kuehn; Gerald Denk; David Horst; Ronald Oude Elferink; Ulrich Beuers
Journal:  Cells       Date:  2020-01-23       Impact factor: 6.600

Review 9.  Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology.

Authors:  Luca Maroni; Elisabetta Ninfole; Claudio Pinto; Antonio Benedetti; Marco Marzioni
Journal:  Cells       Date:  2020-03-17       Impact factor: 6.600

10.  A Low FUT(2) Diet For a High-Fat World: Connecting Intestinal Fucosylation With Western Diet-Driven Liver Disease.

Authors:  Rachel R Stine
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2021-05-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.